Targhetta, C <br/><br/>
Risk of HBV liver disease in isolated antiHbc patients receiving immuno-chemotherapy for non Hodgkin lymphoma.  [electronic resource] 

 -  Haematologica  Nov 2008 
 - e66 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1592-8721 
<br/><br/><label>Standard No.: </label>10.3324/haematol.13750  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antiviral Agents--therapeutic use<br/>Hepatitis B--drug therapy<br/>Hepatitis C--drug therapy<br/>Humans<br/>Immunotherapy<br/>Lymphoma, Non-Hodgkin--drug therapy<br/>Risk Factors